Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain

By Clemens Katri Elina   Mikus Gerd  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 297-310

Informa Healthcare

Access to resources Recommend Favorite

Ultraselective antagonists of the d-opioid receptor

By Lazarus L.H.   Salvadori S.   Temussi P.A.   Balboni G.   Guerrini R.   Bryant S.D.   Cooper P.S.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 45-47

Informa Healthcare

Access to resources Recommend Favorite

Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats

By Gallate Jason   Mallet Paul   McGregor Iain  

Psychopharmacology, Vol. 173, Iss. 1-2, 2004-04 ,pp. : 210-216

Springer Publishing Company

Access to resources Recommend Favorite

Opioid Receptor Antagonists in Psychiatry: Beyond Drug Addiction

By Rénéric J-P.   Bouvard M.P.  

CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 365-382

Adis International

Access to resources Recommend Favorite

Safety of neurokinin-1 receptor antagonists

By Muñoz Miguel   Coveñas Rafael  

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 673-685

Informa Healthcare

Access to resources Recommend Favorite